Shri Ahimsa Naturals Ltd IPO

Our Company primarily processes crude caffeine procured from multiple decaffeination plants. The primary raw material is crude caffeine, a bi-product of such decaffeination plants. We process crude caffeine to manufacture Green Coffee Beans Extracts (GCE) and Caffeine Anhydrous Natural. Our Company's business focused on extraction, manufacturing & sale of Caffeine Anhydrous Natural. To capitalize on this opportunity, our Company developed a process to extract GCE from the crude caffeine & subsequently added GCE to its product portfolio. In response to growing demand for other herbal extracts from its customers, Company expanded its product portfolio to include various herbal extracts in year 2021. Since 2022, our Company has started manufacturing Crude Caffeine from Tea waste & Coffee waste, which is sold in open market & also used for captive consumption.

Open Demat Account

50years

Shri Ahimsa Naturals Ltd IPO Details

Details

Total Shares OfferedOffer to PublicRetail Max (Shares)Pre Issue Promoters HoldingExchangeIssue size
₹ 62.03 L₹ 19.99 L₹ 20.82 L₹ 180.23 LNSE₹ 73.81 Cr
IPO Open DateClose DateLot SizeMin InvestmentIssue TypeListing Date
25 Mar, 2527 Mar, 251200 ₹ 1,35,600 Book Building - SME03 Apr, 25

Shri Ahimsa Naturals Ltd IPO Dates

  • 25 Mar 2025

    Opening date

  • 27 Mar 2025

    Closing date

  • 28 Mar 2025

    Basis of
    Allotment

  • 02 Apr 2025

    Initiation of
    Refunds

  • 02 Apr 2025

    Credit of
    Shares

  • 03 Apr 2025

    Listing date

Details

SectorType
SectorPharmaceuticals - Indian - Bulk Drugs & Formln
Sub SectorNA
Issue TypeBook Building - SME

Subscription Status

*Values are in Lakhs

Investor TypeSubscription TimesShares Offered*Shares Bid*
QIB0x29244000
NII0x8844000
Retail0x20820000
Employee0x00
Total0x62028000

Subscription Status

Investor Type

QIB

NII

Retail

Employee

Total

*Values are in Lakhs

Shri Ahimsa Naturals Ltd Financial Status

Income Statement

Balance Sheet

Particulars (in Rs. Crores)FY23FY22FY21
Revenue from operations77.98103.8916.86
EBITDA28.3352.7617.72
PAT20.9635.7111.27
Total Assets53.4938.3316.94
Share Capital18.325.245.24
Total Borrowings18.278.8410.95
Operating Activities (Net Cash)22.4536.8112.13
Investing Activities (Net Cash)3.40-2.79-2.66
Financing Activities (Net Cash)18.278.8410.95
Net Cashflow7.979.502.65

Particulars (in Rs. Crores)

Revenue from operations

EBITDA

PAT

Total Assets

Share Capital

Total Borrowings

Operating Activities (Net Cash)

Investing Activities (Net Cash)

Financing Activities (Net Cash)

Net Cashflow

About Shri Ahimsa Naturals Ltd

Shri Ahimsa Naturals Limited was originally incorporated in the name and style of `Ahimsa Mines and Minerals Private Limited' under the Companies Act, 1956 with the Registrar of Companies, Jaipur, on October 17, 1990. Further, the name of the Company was changed to `Shri Ahimsa Mines and Minerals Private Limited', and a fresh certificate of incorporation dated July 14, 1992 was issued by the RoC, Jaipur. Subsequently, the constitution of Company was changed from a Private Limited Company to a Public Limited Company and consequently the name of the Company was changed to `Shri Ahimsa Mines and Minerals Limited', and a fresh certificate of incorporation dated August 19, 1992 was issued by the RoC, Jaipur. The name of the Company was further changed to `Shri Ahimsa Naturals Limited', and a fresh certificate of incorporation dated April 25, 2023 was issued by the RoC, Jaipur.

The Caffeine Anhydrous market has experienced significant growth, with a valuation of USD 622.4 Million in 2023, projected to reach USD 881.5 Million by 2030, showcasing a steady Compound Annual Growth Rate (CAGR) of 6.88% during the forecast period of 2024-2030. This expansion is propelled by the increasing adoption of Anhydrous Caffeine across various end-use verticals, notably in the beverage industry and dietary supplements sector. Several factors contribute to the expanding Anhydrous Caffeine market, including heightened health awareness, the prevalence of obesity among adults, escalating demand from athletes, and its utilization as supplements for diet and weight loss purposes. The prevalence of obesity and overweight offers has spurred consumer interest in weight loss supplements, thereby strengthening the demand for Anhydrous Caffeine due to its nerve stimulant properties, which have been found beneficial for weight control. Global demand for Caffeine continues to rise, prompting manufacturers to invest in producing superior quality Caffeine products. Coffee, as one of the world's most favored beverages, plays a pivotal role in this market dynamic, with coffee beans ranking as the second most heavily traded commodity globally. Notably, consumer preferences are shifting towards low and no-calorie beverages, with increasing emphasis on scrutinizing ingredients like Caffeine and preservatives, as highlighted by a recent survey conducted by the International Food Information Council (IFIC).

Our Company primarily processes crude caffeine procured from multiple decaffeination plants. The primary raw material is crude caffeine, a bi-product of such decaffeination plants. We process crude caffeine to manufacture Green Coffee Beans Extracts (GCE) and Caffeine Anhydrous Natural. Our Company's business focused on extraction, manufacturing & sale of Caffeine Anhydrous Natural. To capitalize on this opportunity, our Company developed a process to extract GCE from the crude caffeine & subsequently added GCE to its product portfolio. In response to growing demand for other herbal extracts from its customers, Company expanded its product portfolio to include various herbal extracts in year 2021. Since 2022, our Company has started manufacturing Crude Caffeine from Tea waste & Coffee waste, which is sold in open market & also used for captive consumption.

Peer Comparison:

  • No listed Industries Peers

Shri Ahimsa Naturals Ltd IPO Key Points

Strengths

  • Experienced Promoters and Management Team.
  • Manufacturing facility supported by technology driven process and R&D capabilities.
  • Quality Service.
  • Long term relationship with the clients.
  • Healthy relationship with Crude Caffeine Suppliers.

Risk

  • The Primary Object to issue is Investment in Wholly Owned Subsidiary which is setting up a manufacturing unit (Proposed Project). Such Proposed Project is subject to the risk of unanticipated delays in implementation, cost overruns and certain Government approvals and licenses. If we are unable to implement the expansion plans at the planned cost or time or unable to obtain Government approvals and licenses, it could materially and adversely impact our business, results of operations and financial condition.
  • Our Statutory Auditors have included certain qualifications in the annexure to their audit reports, for half year ended September 30, 2024 and the years ended March 31, 2024, March 31, 2023 and March 31, 2022.
  • Our Company plans to invest an estimated sum of ?3,500 lakhs out of the Net proceeds of the Issue in our Wholly Owned Subsidiary namely Shri Ahimsa Healthcare Private Limited for setting up a manufacturing unit (Proposed Project). In the event of any delay in placing these orders, or if the vendors are not able to provide the equipment / machinery or complete the civil and related works etc. in a timely manner, or at all, may result in time and cost over-runs.

Strategy

  • Expand our manufacturing capacities to capture additional market share.
  • Increasing our global footprint and augmenting growth in current geographies.
  • Continuous Research & Development to Improve Efficiency.
  • Expand our supplier base.
  • Focus on Increase in Volume of Sales.
  • Experienced Promoters and Management Team.
  • Manufacturing facility supported by technology driven process and R&D capabilities.
  • Quality Service.
  • Long term relationship with the clients.
  • Healthy relationship with Crude Caffeine Suppliers.

How To Apply for Shri Ahimsa Naturals Ltd IPO Online?

Step 1:

Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

Get your FAQs right

Shri Ahimsa Naturals Ltd's IPO offers shares for up to ₹ 0 L It begins on Mar 25, 2025 and ends on Mar 27, 2025.

The price of Shri Ahimsa Naturals Ltd IPO ranges between ₹113 to ₹119 per share.

The Shri Ahimsa Naturals Ltd IPO opens on Mar 25, 2025 and closes on Mar 27, 2025.

The allotment for the Shri Ahimsa Naturals Ltd IPO will be finalised on Mar 28, 2025. The shares will be listed on BSE and NSE on Apr 3, 2025.

The minimum lot size for Shri Ahimsa Naturals Ltd IPO is 1200 shares, priced between ₹113 to ₹119 per share.

The GMP (Grey Market Premium) of Shri Ahimsa Naturals Ltd IPO fluctuates based on market demand and sentiment.

To check the allotment status of Shri Ahimsa Naturals Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

The Shri Ahimsa Naturals Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Mar 25, 2025, and closes on Mar 27, 2025. The allotment is finalised on Mar 28, 2025.

To apply for the Shri Ahimsa Naturals Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.